Kinehara Yuhei, Kida Hiroshi, Inoue Yoshikazu, Hirose Masaki, Nakabayashi Akihiko, Takeuchi Yoshiko, Hayama Yoshitomo, Fukushima Kiyoharu, Hirata Haruhiko, Inoue Koji, Minami Toshiyuki, Nagatomo Izumi, Takeda Yoshito, Funakoshi Toshiki, Kijima Takashi, Kumanogoh Atsushi
Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.
BMC Pulm Med. 2014 Nov 4;14:172. doi: 10.1186/1471-2466-14-172.
Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare lung disease caused by the autoantibody against granulocyte-macrophage colony stimulating factor (GM-CSF). The clinical course of aPAP is variable; in severe cases, patients develop lethal respiratory failure due to pulmonary fibrosis. However, the pathogenesis of pulmonary fibrosis in aPAP has never been delineated.
Here, we describe a rare case of aPAP that was subsequently complicated by microscopic polyangiitis-related pulmonary fibrosis. The patient was a 75-year-old Japanese man diagnosed with aPAP based on the crazy-paving appearance on high-resolution computed tomography (HRCT), "milky" appearance of broncho-alveolar lavage fluid (BALF), and elevated serum levels of the anti-GM-CSF antibody. The patient was followed-up without aPAP-specific treatment for 3 years. During this period, both hematuria and proteinuria appeared; in addition, serum myeloperoxidase (MPO)-anti-neutrophil cytoplasmic antibody (ANCA) turned positive and increased markedly. The second BAL performed one year after the diagnosis, showed that the "milky" appearance had resolved. The HRCT showed that fibrotic changes had developed and that the crazy-paving appearance had disappeared. These data suggest an association between pulmonary fibrosis that developed during the natural course of aPAP and ANCA-related systemic vasculitis.
This is the first case report that suggests the existence of a pathogenetic relationship between ANCA-associated systemic vasculitis and aPAP-related pulmonary fibrosis. The link between ANCA-associated systemic vasculitis and aPAP-related pulmonary fibrosis requires further investigation.
自身免疫性肺泡蛋白沉积症(aPAP)是一种由抗粒细胞-巨噬细胞集落刺激因子(GM-CSF)自身抗体引起的罕见肺部疾病。aPAP的临床病程具有多样性;在严重病例中,患者会因肺纤维化而发展为致命的呼吸衰竭。然而,aPAP中肺纤维化的发病机制尚未明确。
在此,我们描述了一例罕见的aPAP病例,该病例随后并发了显微镜下多血管炎相关的肺纤维化。患者为一名75岁的日本男性,根据高分辨率计算机断层扫描(HRCT)上的铺路石样表现、支气管肺泡灌洗(BALF)液的“乳状”外观以及抗GM-CSF抗体血清水平升高,被诊断为aPAP。该患者在未接受aPAP特异性治疗的情况下随访了3年。在此期间,出现了血尿和蛋白尿;此外,血清髓过氧化物酶(MPO)-抗中性粒细胞胞浆抗体(ANCA)转为阳性且显著升高。诊断后一年进行的第二次BAL显示,“乳状”外观已消失。HRCT显示出现了纤维化改变,铺路石样外观消失。这些数据表明aPAP自然病程中出现的肺纤维化与ANCA相关的系统性血管炎之间存在关联。
这是首例提示ANCA相关系统性血管炎与aPAP相关肺纤维化之间存在发病机制联系的病例报告。ANCA相关系统性血管炎与aPAP相关肺纤维化之间的联系需要进一步研究。